Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Northwestern University
Uppsala University
Sheffield Teaching Hospitals NHS Foundation Trust
Information provided by (Responsible Party):
Richard Burt, MD, Northwestern University Identifier:
First received: January 5, 2006
Last updated: June 13, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):